Age Differences in Comorbidities, Presenting Symptoms, and Outcomes of Influenza Illness Requiring Hospitalization: A Worldwide Perspective From the Global Influenza Hospital Surveillance Network
Melissa K. Andrew, Henrique Pott, Lisa Staadegaard, John Paget, Sandra S. Chaves, Justin R. Ortiz, John W. McCauley, Joseph Bresee, Marta C. Nunes, Elsa Baumeister, Sônia Mara Raboni, H. I. G. GIAMBERARDINO, Shelly McNeil, Doris Gómez, Tao Zhang, Philippe Vanhems, Parvaiz A Koul, Daouda Coulibaly, Nancy A. Otieno, Ghassan Dbaibo, M. Lourdes Guerrero Almeida, V. Alberto Laguna-Torres, Anca Cristina Drăgănescu, Burtseva Ei, А. А. Соминина, Daria Danilenko, Snežana Medić, Javier Díez‐Domingo, Bruno Lina
Abstract
Abstract Background The Global Influenza Hospital Surveillance Network (GIHSN) was established in 2012 to conduct coordinated worldwide influenza surveillance. In this study, we describe underlying comorbidities, symptoms, and outcomes in patients hospitalized with influenza. Methods Between November 2018 and October 2019, GIHSN included 19 sites in 18 countries using a standardized surveillance protocol. Influenza infection was laboratory-confirmed with reverse-transcription polymerase chain reaction. A multivariate logistic regression model was utilized to analyze the extent to which various risk factors predict severe outcomes. Results Of 16 022 enrolled patients, 21.9% had laboratory-confirmed influenza; 49.2% of influenza cases were A/H1N1pdm09. Fever and cough were the most common symptoms, although they decreased with age (P < .001). Shortness of breath was uncommon among those <50 years but increased with age (P < .001). Middle and older age and history of underlying diabetes or chronic obstructive pulmonary disease were associated with increased odds of death and intensive care unit (ICU) admission, and male sex and influenza vaccination were associated with lower odds. The ICU admissions and mortality occurred across the age spectrum. Conclusions Both virus and host factors contributed to influenza burden. We identified age differences in comorbidities, presenting symptoms, and adverse clinical outcomes among those hospitalized with influenza and benefit from influenza vaccination in protecting against adverse clinical outcomes. The GIHSN provides an ongoing platform for global understanding of hospitalized influenza illness.